2D Genetic Map of Prostate Cells Charts Cancer Growth

An in situ map of copy number variations in prostate tissue reveals that purportedly cancerous genomic changes frequently occur in the healthy tissue surrounding tumors.

Written byHolly Barker, PhD
| 4 min read
Histological slide showing cancerous prostate tissue
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In a study published August 10 in Nature, scientists have charted the genetic landscape across a human prostate in high resolution and discovered how additional or missing chunks of chromosomes, known as copy number variations, thought to be unique to cancer are often present in seemingly healthy tissue.

“This was surprisingly and completely unexpected,” says study coauthor Alastair Lamb, a urologist at Oxford University’s Nuffield Department of Surgical Sciences. “We thought that these kinds of changes defined prostate cancer. But they are present in [tissue] which is entirely benign.”

Far from a uniform mass of cells, tumors consist of a patchwork of malignant, benign, and healthy tissues. Understanding how normal cells become cancerous requires that scientists plot the genetic changes within this complex ecosystem. In collaboration with gene technology researcher Joakim Lundeberg and colleagues at the KTH Royal Institute of Technology in Sweden, Lamb’s team used a technique called spatial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Headshot of Holly Barker

    Holly Barker is a freelance writer based in London. She has a PhD in clinical neuroscience from King’s College London and a degree in biochemistry from the University of Manchester. She has previously written for Discover and Spectrum News.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies